인사이드, 파이낸스, 인더스트리, 엔터미디어 등 관련기사 제공

NTS Launches Tax Probe Into MBK Partners' Stake Sale: Paul Lee 2025.04.23

LS Mtron Illegally Patented Small Firm’s Core Technology, Says Supreme Court: Paul Lee 2025.04.23

NH NongHyup Bank Uncovers ₩20 Billion Mortgage Loan Fraud by External Consultant: Paul Lee 2025.04.23

U.S. to Impose Tariffs of Up to 3,500% on Chinese Solar Products Manufactured in Southeast Asia: Paul Lee 2025.04.23

SK Telecom Responds Swiftly to Suspected Data Breach Following Hacking Incident: Paul Lee 2025.04.23

KORAIL Secures 10-Year, 120 Billion KRW Contract for Operation and Maintenance of Manila MRT-7 Line: Paul Lee 2025.04.23

SK Telecom Investigates Potential Data Breach Following Internal System Hack: Paul Lee 2025.04.23

Korea’s Fair Trade Commission Set to Impose Heavier Fines on Top Banks Over Alleged LTV Collusion: Paul Lee 2025.04.22

Consumer Complaints Surge After Tving Bans Account Sharing Outside Household: Paul Lee 2025.04.22

Semiconductor Stocks Slide as Nvidia Plunges 4.5% Amid Huawei AI Chip Concerns: Paul Lee 2025.04.22

Eugene Group Injects KRW 20 Billion into YTN via Third-Party Allotment Capital Increase: Paul Lee 2025.04.22

KT&G to Sell Courtyard Marriott Seoul Namdaemun Hotel as Part of Ongoing Real Estate Asset Rebalancing: Paul Lee 2025.04.22

Busan Customs Raids Geumyang Headquarters Over Suspected Irregularities in Mongolian Mine Investment: Paul Lee 2025.04.22

CJ Logistics Construction Wins Contract for Nongshim’s New Ulsan Samnam Logistics Center: Paul Lee 2025.04.22

Korean FTC Fines Gravity and Wemade for Misleading Loot Box Probabilities: Paul Lee 2025.04.22

FuriosaAI-Linked Stocks Surge Amid Hopes of Unicorn Status: Paul Lee 2025.04.21

Leadership Dispute at Daol Investment & Securities Appears Resolved as Second-Largest Shareholder Sells Stake: Paul Lee 2025.04.21

Duzon Bizon Becomes Second-Largest Shareholder of Jeju Bank with ₩57 Billion Investment: Paul Lee 2025.04.21

KB Kookmin Bank Reports ₩2.2 Billion Loan Fraud, Second Financial Incident This Year: Paul Lee 2025.04.21

Il-Yang Pharmaceutical Cleared of Stock Manipulation Allegations: Paul Lee 2025.04.21